AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nichi-Iko Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash from investing

Nichi-Iko Pharmaceutical Co., Ltd.【JP:E00963】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2022-9,315-68.25%
Mar 31, 2021-29,334+60.93%
Mar 31, 2020-18,228-27.04%
Mar 31, 2019-24,983+57.17%
Mar 31, 2018-15,896-80.56%
Mar 31, 2017-81,754+2245.88%
Mar 31, 2016-3,485-76.21%
Mar 31, 2015-14,647

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)